secwatch.observer — SEC 8-K summary
======================================

Issuer:     NexImmune, Inc. (—)
CIK:        0001538210
Form:       8-K
Filed at:   2023-08-31T23:59:59+00:00
Accession:  0001193125-23-226404
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 2.05, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

NexImmune cuts workforce 53%, CFO departs; expects $2.3M in severance costs
---------------------------------------------------------------------------

- Workforce reduced from 47 to 22 employees (~53% cut) effective September 5, 2023.
- Estimated $2.3 million in severance and termination costs, primarily in Q3 fiscal 2023.
- CFO John Trainer employment ends September 2; he will transition to consulting role.
- VP Corporate Controller Timothy Stover appointed new Principal Financial and Accounting Officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1538210/000119312523226404/0001193125-23-226404-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1538210/000119312523226404/d689875d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-226404

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer